Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged≥3 to <12 Years

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.44